LUGANO, Switzerland–(BUSINESS WIRE)–#Antiaging–Contrad Swiss, a pharmaceutical company focused on breakthrough,
innovative products that reframe the world of medicine, announces a new
partnership with Dr JO Serrentino to bring to the market effective
biomedical remedies unlike any other.
SIGMOLECS® Technology was conceived and engineered by Dr
Serrentino exclusively for Contrad Swiss.
SIGMOLECS® uses the highest bioavailable signaling molecules
to summon and target biological pathways for precise programming at the
cellular level. The result is like a program code of the cells,
deploying them to organize into specific patterns. SIGMOLECS®
talks to the cells in their language.
ACTV8SKN® – Actuator – contains the exclusive SIGMOLECS®
Technology.
ACTV8SKN® is an odorless fluid gel of peptide-bonded amino
acids, specifically engineered for a complete signaling spectrum that
awakens cell cycles of the skin. It can be used in clinic to enhance
procedures or dispensed to patients as a follow up take-home product.
Easy to use, a few drops of ACTV8SKN® to cleansed face. The
fluid gel will absorb as soon as it is spread.
Information on the development, novel characteristics of SIGMOLECS®
Technology and clinical data supporting the long-lasting efficacy of the
most advanced regenerative cosmetic available today, can be requested. www.contrad.ch
About Contrad Swiss
Contrad Swiss is the most innovative pharmaceutical corporation
specialized in OTC, medical devices, functional cosmetics and dietary
supplements. The innovation can be expressed in the formula, in a new
way of administration or a novel application. All the products are
respected for their solid scientific support and they carry the consumer
recognition of quality and convenience.
About Dr JO Serrentino
M.Sc; DVM; Ph.D FAARM; DABRM. Master’s in Biochemistry; Veterinarian;
Doctorate in clinical ecology/environmental medicine. Fellow of the
American Academy of Regenerative Medicine; Diplomat of the American
Board of Regenerative Medicine.
Extensive expertise in the following areas:
- Protein sequencing and clones for biological new medicine;
- Peptide inclusion for medicine;
-
Use of cytokines in medicine and therapy and as pathophysiological
markers. -
Biological markers for diagnostics; targeting and research&
development; -
Carrier formulations for enhanced absorption of active principles;
formulating, assessment and/or amendment; -
Molecular manipulation for enhanced biological properties esp. with
protein (cytokine) and gene therapy; - Metabolic Syndromes and Energy Metabolism;
- Stem cell extenders and methodologies for clinical application;
-
Orthopaedic biologicals for clinical application in Regenerative
Medicine.
Contacts
Carmen Gerardi
Contrad Swiss SA
+41-79-473-4657
Lugano
(CH)
carmen.gerardi@contrad.ch